Open AccessFinancial Implications of Avapritinib for Treatment of Unresectable Gastrointestinal Stromal Tumors in Patients With a PDGFRA Exon 18 Variant or After 3 Previous Therapies in a Hypothetical US Health Plan
Author(s) -
David Proudman,
Aaron Miller,
Dave Nellesen,
Aparna Gomes,
Raymond Mankoski,
Chelsea Norregaard,
Erin Sullivan
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.25866
Subject(s) - pdgfra , gist , medicine , formulary , oncology , medicare advantage , population , health care , family medicine , stromal cell , environmental health , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom